ArticleScientific reports2024

PDIA2 is associated with the prognosis of prostate cancer, and downregulation of PDIA2 delays the progression of prostate cancer cells.

Qiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.